JACKSONVILLE, Fla., June 5, 2025 /PRNewswire/ — Advanced Biological Research Group (ABRG), a 501c3, has announced its second study to determine the effects of mRNA on women’s reproductive systems. The group’s 2024 pilot study focused on abnormal vaginal bleeding after exposure to mRNA and also the impact of mRNA shedding.
The new 2025 study will investigate the causes of the decrease in ovarian egg reserve and the overall decline in female fertility, as reported by a growing number of OB/GYNs globally.
The ABRG team includes founding members Kimberly Biss, MD, Kirstin Cosgrove BM, CCRA, Ryan Cole, MD, Dan McDyer, MD, noted specialist in maternal-fetal medicine, James A. Thorp, MD. and Dr. Steven J. Hatfill Emeritus, who now serves as Senior Adviser to the Secretary of Health and Human Services (HHS).
Dr. Thorp recently testified in front of the Senate Permanent Sub-Committee on Investigations (Senator Ron Johnson, WI [Chairman]; Senator Richard Blumenthal, CT [Ranking Member]) on the issue of mRNA vaccine adverse effects in the most vulnerable patients: pregnant woman, the unborn and newborn children. Members Dr. Biss and Dr. Cole had testified previously on several topics, including adverse effects in reproduction and the mRNA platform.
For information on supporting ABRG and its studies, please contact:
396338@email4pr.com or visit abrg.org.
Please direct all media inquiries to RECURSION MEDIA GROUP Inc. 396338@email4pr.com or 352-282-0778, or visit recursionmediagroup.com.
Recursion Media Group, Inc. (RMG) owns and operates Recursion Publishing, RMG Innovations, Recursion.Live, and RMG News Daily. For more information, please visit recursionmediagroup.com
SOURCE Advanced Biological Research Group
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…